Advertisement

Subset Analysis of Response to Treatment of Chronic Phase CML in a Phase 1 Study of Ponatinib in Refractory Hematologic Malignancies

Jorge E. Cortes, Hagop M. Kantarjian, Neil Shah, Dale Bixby, Michael J. Mauro, Ian W. Flinn, Thomas O'Hare, Simin Hu, Tim Clackson, Victor M. Rivera, Christopher D. Turner, Frank Haluska, Brian J. Druker, Michael W. Deininger and Moshe Talpaz

Article Information

Citation 
vol. 118 no. 21 602

Print ISSN 
Online ISSN 
History 
  • Published online October 19, 2015.


Contributors 
  • Jorge E. Cortes, 1The University of Texas MD Anderson Cancer Center, Houston, TX, USA,
  • Hagop M. Kantarjian, 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,
  • Neil Shah [MD, PhD], 3University of California San Francisco, San Francisco, CA, USA,
  • Dale Bixby [MD, PhD], 4University of Michigan, Comprehensive Cancer Center, Ann Arbor, MI, USA,
  • Michael J. Mauro [MD], 5Oregon Health & Science University, Portland, OR, USA,
  • Ian W. Flinn [MD, PhD], 6Sarah Cannon Research Institute, Nashville, TN, USA,
  • Thomas O'Hare, 7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA,
  • Simin Hu [PhD], 8ARIAD Pharmaceuticals Inc, Cambridge, MA, USA
  • Tim Clackson [PhD], 8ARIAD Pharmaceuticals Inc, Cambridge, MA, USA
  • Victor M. Rivera [PhD], 8ARIAD Pharmaceuticals Inc, Cambridge, MA, USA
  • Christopher D. Turner [MD, FAAP], 8ARIAD Pharmaceuticals Inc, Cambridge, MA, USA
  • Frank Haluska [MD, PhD], 8ARIAD Pharmaceuticals Inc, Cambridge, MA, USA
  • Brian J. Druker, 5Oregon Health & Science University, Portland, OR, USA,
  • Michael W. Deininger, 7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA,
  • Moshe Talpaz [MD], 4University of Michigan, Comprehensive Cancer Center, Ann Arbor, MI, USA,

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output